Benign thyroid disease in pregnancy: A state of the art review

Journal of Clinical and Translational Endocrinology

Volumn 6, Issue , 2016, Pages 37-49

  Tingi, Efterpi ^a   Syed, Akheel A ^b,c   Kyriacou, Alexis ^d,e   Mastorakos, George ^f   Kyriacou, Angelos ^b,e  

^a ST MARY S HOSPITAL   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF STIRLING   (United Kingdom)

^e CEDM Centre of Endocrinology   (Cyprus)

^f UNIVERSITY OF ATHENS   (Greece)

Author keywords

Autoimmune thyroid disease; Hyperthyroidism; Hypothyroidism; Iodine; Pregnancy; Thioamides; Thyroiditis

Indexed keywords

ANTITHYROID AGENT; IODINE; LEVOTHYROXINE; THYROID ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

AUTOIMMUNE THYROIDITIS; BRAIN DEVELOPMENT; EARLY DIAGNOSIS; FEMALE; FETUS DEVELOPMENT; FETUS OUTCOME; GESTATIONAL HYPERTHYROIDISM; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; IODINE DEFICIENCY; ISOLATED HYPOTHYROXINEMIA; OVERT HYPOTHYROIDISM; POSTPARTUM THYROIDITIS; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID CRISIS; THYROID DISEASE; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

EID: 85000763528     PISSN: None     EISSN: 22146237     Source Type: Journal    
DOI: 10.1016/j.jcte.2016.11.001     Document Type: Review

References (113)

1. [1] Vanderpump, M.P.J., The epidemiology of thyroid disease. Br Med Bull 99 (2011), 39–51.
2. [2] Kyriacou, A., McLaughlin, J., Syed, A.A., Thyroid disorders and gastrointestinal and liver dysfunction: A state of the art review. Eur J Intern Med 26 (2015), 563–571.
3. [3] Santoro, N., Braunstein, G.D., Butts, C.L., Martin, K.A., McDermott, M., Pinkerton, J.V., Compounded bioidentical hormones in endocrinology practice: an endocrine society scientific statement. J Clin Endocrinol Metab 101 (2016), 1318–1343.
4. [4] Glinoer, D., The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18 (1997), 404–433.
5. [5] Weeke, J., Dybkjaer, L., Granlie, K., Eskjaer Jensen, S., Kjaerulff, E., Laurberg, P., et al. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol (Copenh) 101 (1982), 531–537.
6. [6] Ballabio, M., Poshychinda, M., Ekins, R.P., Pregnancy-induced changes in thyroid function: role of human chorionic gonadotropin as putative regulator of maternal thyroid. J Clin Endocrinol Metab 73 (1991), 824–831.
7. [7] Lazarus, J., Brown, R.S., Daumerie, C., Hubalewska-Dydejczyk, A., Negro, R., Vaidya, B., European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J 3 (2014), 76–94.
8. [8] Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21 (2011), 1081–1125.
9. [9] De Groot, L., Abalovich, M., Alexander, E.K., Amino, N., Barbour, L., Cobin, R.H., et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97 (2012), 2543–2565.
10. [10] Zimmermann, M.B., The adverse effects of mild-to-moderate iodine deficiency during pregnancy and childhood: a review. Thyroid 17 (2007), 829–835.
11. [11] Qian, M., Wang, D., Watkins, W.E., Gebski, V., Yan, Y.Q., Li, M., et al. The effects of iodine on intelligence in children: a meta-analysis of studies conducted in China. Asia Pac J Clin Nutr 14 (2005), 32–42.
12. [12] WHO, Assessment of iodine deficiency disorders and monitoring their elimination, 2007. Available from: http://www.who.int/nutrition/publications/micronutrients/iodine_deficiency/9789241595827/en/.
13. [13] Taylor, P.N., Vaidya, B., Iodine supplementation in pregnancy - is it time?. Clin Endocrinol (Oxf), 2016, 10.1111/cen.13065.
14. [14] Zimmermann, M., Delange, F., Iodine supplementation of pregnant women in Europe: a review and recommendations. Eur J Clin Nutr 58 (2004), 979–984.
15. [15] Bath, S.C., Steer, C.D., Golding, J., Emmett, P., Rayman, M.P., Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet 382 (2013), 331–337.
16. [16] Bath, S.C., Rayman, M.P., Iodine deficiency in the U.K.: an overlooked cause of impaired neurodevelopment?. Proc Nutr Soc 72 (2013), 226–235.
17. [17] Bath, S.C., Furmidge-Owen, V.L., Redman, C.W., Rayman, M.P., Gestational changes in iodine status in a cohort study of pregnant women from the United Kingdom: season as an effect modifier. Am J Clin Nutr 101 (2015), 1180–1187.
18. [18] Caldwell, K.L., Pan, Y., Mortensen, M.E., Makhmudov, A., Merrill, L., Moye, J., Iodine status in pregnant women in the National Children's Study and in U.S. women (15–44 years), National Health and Nutrition Examination Survey 2005–2010. Thyroid 23 (2013), 927–937.
19. [19] Pearce, E.N., Andersson, M., Zimmermann, M.B., Global iodine nutrition: Where do we stand in 2013?. Thyroid 23 (2013), 523–528.
20. [20] Hynes, K.L., Otahal, P., Hay, I., Burgess, J.R., Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the offspring: 9-year follow-up of the gestational iodine cohort. J Clin Endocrinol Metab 98 (2013), 1954–1962.
21. [21] Oken, E., Wright, R.O., Kleinman, K.P., Bellinger, D., Amarasiriwardena, C.J., Hu, H., et al. Maternal fish consumption, hair mercury, and infant cognition in a U.S. Cohort. Environ Health Perspect 113 (2005), 1376–1380.
22. [22] Le Donne, M., Alibrandi, A., Vita, R., Zanghì, D., Triolo, O., Benvenga, S., Does eating oily fish improve gestational and neonatal outcomes? Findings from a Sicilian study. Women Birth 29 (2016), e50–e57.
23. [23] Benvenga, S., Vigo, M.T., Metro, D., Granese, R., Vita, R., Le Donne, M., Type of fish consumed and thyroid autoimmunity in pregnancy and postpartum. Endocrine 52 (2016), 120–129.
24. [24] Melse-Boonstra, A., Gowachirapant, S., Jaiswal, N., Winichagoon, P., Srinivasan, K., Zimmermann, M.B., Iodine supplementation in pregnancy and its effect on child cognition. J Trace Elem Med Biol 26 (2012), 134–136.
25. [25] Taylor, P.N., Okosieme, O.E., Dayan, C.M., Lazarus, J.H., Therapy of endocrine disease: Impact of iodine supplementation in mild-to-moderate iodine deficiency: systematic review and meta-analysis. Eur J Endocrinol, 170, 2014, 10.1530/EJE-13-0651.
26. [26] Zhou, S.J., Anderson, A.J., Gibson, R.a., Makrides, M., Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials. Am J Clin Nutr 98 (2013), 1241–1254.
27. [27] Bouhouch, R.R., Bouhouch, S., Cherkaoui, M., Aboussad, A., Stinca, S., Haldimann, M., et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double-blind randomised placebo-controlled trial. Lancet Diabetes Endocrinol 2 (2014), 197–209.
28. [28] Fisher, D.A., Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol 40 (1997), 16–31.
29. [29] Puig-Domingo, M., Vila, L., The implications of iodine and its supplementation during pregnancy in fetal brain development. Curr Clin Pharmacol 8 (2013), 97–109.
30. [30] Thorpe-Beeston, J.G., Nicolaides, K.H., McGregor, A.M., Fetal thyroid function. Thyroid 2 (1992), 207–217.
31. [31] Saki, F., Dabbaghmanesh, M.H., Ghaemi, S.Z., Forouhari, S., Ranjbar Omrani, G., Bakhshayeshkaram, M., Thyroid function in pregnancy and its influences on maternal and fetal outcomes. Int J Endocrinol Metab, 12, 2014, e19378.
32. [32] Haddow, J.E., Palomaki, G.E., Allan, W.C., Williams, J.R., Knight, G.J., Gagnon, J., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341 (1999), 549–555.
33. [33] Alexander, E.K., Marqusee, E., Lawrence, J., Jarolim, P., Fischer, G.A., Larsen, P.R., Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351 (2004), 241–249.
34. [34] Yassa, L., Marqusee, E., Fawcett, R., Alexander, E.K., Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab 95 (2010), 3234–3241.
35. [35] Huang, M.J., Li, K.L., Wei, J.S., Wu, S.S., Fan, K.D., Liaw, Y.F., Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol 89 (1994), 1071–1076.
36. [36] Chang, D.L.F., Pearce, E.N., Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines. J Thyroid Res, 2013, 2013, 851326.
37. [37] Ajmani, S.N., Aggarwal, D., Bhatia, P., Sharma, M., Sarabhai, V., Paul, M., Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on maternal and fetal outcome. J Obstet Gynaecol India 64 (2014), 105–110.
38. [38] Maraka, S., Singh Ospina, N.M., O'Keeffe, D.T., Espinosa De Ycaza, A.E., Gionfriddo, M.R., Erwin, P.J., et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid 26 (2016), 580–590.
39. [39] Brabant, G., Peeters, R.P., Chan, S.Y., Bernal, J., Bouchard, P., Salvatore, D., et al. Management of subclinical hypothyroidism in pregnancy: are we too simplistic?. Eur J Endocrinol 173 (2015), P1–P11.
40. [40] Liu, H., Shan, Z., Li, C., Mao, J., Xie, X., Wang, W., et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid 24 (2014), 1642–1649.
41. [41] Toulis, K.A., Stagnaro-Green, A., Negro, R., Maternal subclinical hypothyroidsm and gestational diabetes mellitus: a meta-analysis. Endocr Pract 20 (2014), 703–714.
42. [42] Ghassabian, A., Bongers-Schokking, J.J., Henrichs, J., Jaddoe, V.W.V., Visser, T.J., Visser, W., et al. Maternal thyroid function during pregnancy and behavioral problems in the offspring: the generation R study. Pediatr Res 69 (2011), 454–459.
43. [43] Li, Y., Shan, Z., Teng, W., Yu, X., Li, Y., Fan, C., et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25–30 months. Clin Endocrinol (Oxf) 72 (2010), 825–829.
44. [44] Henrichs, J., Bongers-Schokking, J.J., Schenk, J.J., Ghassabian, A., Schmidt, H.G., Visser, T.J., et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J Clin Endocrinol Metab 95 (2010), 4227–4234.
45. [45] Julvez, J., Alvarez-Pedrerol, M., Rebagliato, M., Murcia, M., Forns, J., Garcia-Esteban, R., et al. Thyroxine levels during pregnancy in healthy women and early child neurodevelopment. Epidemiology 24 (2013), 150–157.
46. [46] Behrooz, H.G., Tohidi, M., Mehrabi, Y., Behrooz, E.G., Tehranidoost, M., Azizi, F., Subclinical hypothyroidism in pregnancy: intellectual development of offspring. Thyroid 21 (2011), 1143–1147.
47. [47] Lazarus, J.H., Bestwick, J.P., Channon, S., Paradice, R., Maina, A., Rees, R., et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 366 (2012), 493–501.
48. [48] Casey, B., Effect of treatment of maternal subclinical hypothyroidism or hypothyroxinemia on IQ in offspring. Am J Obs Gynaecol, 2015 Available from: http://www.ajog.org/article/S0002-9378(15)01319-8/pdf.
49. [49] Lazarus, J., Brown, R.S., Daumerie, C., Hubalewska-Dydejczyk, A., Negro, R., Vaidya, B., European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J 3 (2014), 76–94.
50. [50] Negro, R., Formoso, G., Mangieri, T., Pezzarossa, A., Dazzi, D., Hassan, H., Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91 (2006), 2587–2591.
51. [51] Korevaar, T.I.M., Muetzel, R., Medici, M., Chaker, L., Jaddoe, V.W.V., de Rijke, Y.B., et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol 4 (2016), 35–43.
52. [52] Chan, S., Boelaert, K., Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy. Clin Endocrinol (Oxf) 82 (2015), 313–326.
53. [53] Moleti, M., Trimarchi, F., Vermiglio, F., Moleti, M., Trimarchi, F., Vermiglio, F., Doubts and concerns about isolated maternal hypothyroxinemia. J Thyroid Res, 2011, 2011, 463029.
54. [54] Casey, B.M., Dashe, J.S., Wells, C.E., McIntire, D.D., Leveno, K.J., Cunningham, F.G., Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 107 (2006), 337–341.
55. [55] Su, P.-Y., Huang, K., Hao, J.-H., Xu, Y.-Q., Yan, S.-Q., Li, T., et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 96 (2011), 3234–3241.
56. [56] Warner, M.H., Beckett, G.J., Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 205 (2010), 1–13.
57. [57] Moleti, M., Lo Presti, V.P., Mattina, F., Mancuso, A., De Vivo, A., Giorgianni, G., et al. Gestational thyroid function abnormalities in conditions of mild iodine deficiency: early screening versus continuous monitoring of maternal thyroid status. Eur J Endocrinol 160 (2009), 611–617.
58. [58] Yu, X., Shan, Z., Li, C., Mao, J., Wang, W., Xie, X., et al. Iron deficiency, an independent risk factor for isolated hypothyroxinemia in pregnant and nonpregnant women of childbearing age in China. J Clin Endocrinol Metab 100 (2015), 1594–1601.
59. [59] Noten, A.M.E., Loomans, E.M., Vrijkotte, T.G.M., van de Ven, P.M., van Trotsenburg, A.S.P., Rotteveel, J., et al. Maternal hypothyroxinaemia in early pregnancy and school performance in 5-year-old offspring. Eur J Endocrinol 173 (2015), 563–571.
60. [60] Knight, B.A., Shields, B.M., Hattersley, A.T., Vaidya, B., Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters. Eur J Endocrinol 174 (2016), 51–57.
61. [61] Krassas, G.E., Poppe, K., Glinoer, D., Thyroid function and human reproductive health. Endocr Rev 31 (2010), 702–755.
62. [62] Tan, J.Y.L., Loh, K.C., Yeo, G.S.H., Chee, Y.C., Transient hyperthyroidism of hyperemesis gravidarum. BJOG 109 (2002), 683–688.
63. [63] Marx, H., Amin, P., Lazarus, J.H., Hyperthyroidism and pregnancy. BMJ 336 (2008), 663–667.
64. [64] Patil-Sisodia, K., Mestman, J.H., Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract 16 (2010), 118–129.
65. [65] Labadzhyan, A., Brent, G.A., Hershman, J.M., Leung, A.M., Kersten, I., Lange, A.E., et al. Thyrotoxicosis of pregnancy. J Clin Transl Endocrinol 1 (2014), 140–144.
66. [66] Nelson-Piercy, C., Handbook of obstetric medicine. 4th ed., 2010, Medicine & Health Science Books @ Amazon.com 9781841847375, 95–107.
67. [67] Momotani, N., Ito, K., Hamada, N., Ban, Y., Nishikawa, Y., Mimura, T., Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) 20 (1984), 695–700.
68. [68] Galofre, J.C., Davies, T.F., Autoimmune thyroid disease in pregnancy: a review. J Womens Health (Larchmt) 18 (2009), 1847–1856.
69. [69] Yoshihara, A., Noh, J., Yamaguchi, T., Ohye, H., Sato, S., Sekiya, K., et al. Treatment of graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 97 (2012), 2396–2403.
70. [70] Ross, D.S., Burch, H.B., Cooper, D.S., Greenlee, M.C., Laurberg, P., Maia, A.L., et al. American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26 (2016), 1343–1421.
71. [71] Gorman, C.A., Radioiodine and pregnancy. Thyroid 9 (1999), 721–726.
72. [72] Vos, X.G., Smit, N., Endert, E., Tijssen, J.G.P., Wiersinga, W.M., Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves’ hyperthyroidism: a prospective study. Clin Endocrinol (Oxf) 69 (2008), 311–317.
73. [73] Andersen, S.L., Olsen, J., Wu, C.S., Laurberg, P., Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab 98 (2013), 4373–4381.
74. [74] Clementi, M., Di Gianantonio, E., Cassina, M., Leoncini, E., Botto, L.D., Mastroiacovo, P., et al. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 95 (2010), E337–E341.
75. [75] Bowman, P., Vaidya, B., Suspected spontaneous reports of birth defects in the UK associated with the use of carbimazole and propylthiouracil in pregnancy. J Thyroid Res, 2011, 2011, 235130.
76. [76] Li, X., Liu, G.-Y., Ma, J.-L., Zhou, L., Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis. Clinics (Sao Paulo) 70 (2015), 453–459.
77. [77] Andersen, S.L., Olsen, J., Laurberg, P., Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab 101 (2016), 1606–1614.
78. [78] Poppe, K., Hubalewska-Dydejczyk, A., Laurberg, P., Negro, R., Vermiglio, F., Vaidya, B., Management of hyperthyroidism in pregnancy: results of a survey among members of the European thyroid association. Eur Thyroid J 1 (2012), 34–40.
79. [79] Burch, H.B., Cooper, D.S., Management of graves disease: a review. JAMA 314 (2015), 2544–2554.
80. [80] Syed, A.A., Jones, N.A.G., Perros, P., Medical image. Acute pretibial myxoedema following thyroidectomy for Graves’ disease. N Zngl Med J 121 (2008), 108–109.
81. [81] Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., Tørring, O., TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158 (2008), 69–75.
82. [82] Cooper, D.S., Laurberg, P., Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol 1 (2013), 238–249.
83. [83] Azizi, F., Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. J Pediatr 128 (1996), 855–858.
84. [84] Azizi, F., Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism: results of a retrospective study. J Endocrinol Invest 26 (2003), 301–304.
85. [85] Lamberg, B., Ikonen, E., Osterlund, K., Teramo, K., Pekonen, F., Peltola, J., et al. Antithyroid treatment of maternal hyperthyroidism during lactation. Clin Endocrinol (Oxf), 1984, 81–87.
86. [86] Glatstein, M.M., Garcia-Bournissen, F., Giglio, N., Finkelstein, Y., Koren, G., Pharmacologic treatment of hyperthyroidism during lactation. Can Fam Physician 55 (2009), 797–798.
87. [87] Garber, J., Cobin, R., Gharib, H., Hennessey, J., Klein, I., Mechanick, J., et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American association of clinical endocrinologists and the American thyroid association. Endocr Pract 18 (2012), 988–1028.
88. [88] Neill, A.-M.C., Nelson-Piercy, C., Hyperemesis gravidarum. Obstet Gynaecol 5 (2003), 204–207.
89. [89] Body, C., Christie, J.A., Gastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea. Gastroenterol Clin North Am, 2016, 267–283.
90. [90] Coulon, A.L., Savagner, F., Briet, C., Vernin, M., Munier, M., Chabre, O., et al. Prolonged and severe gestational thyrotoxicosis due to enhanced hCG sensitivity of a mutant thyrotropin receptor. J Clin Endocrinol Metab 101 (2016), 10–11.
91. [91] Rodien, P., Brémont, C., Sanson, M.L., Parma, J., Van Sande, J., Costagliola, S., et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 339 (1998), 1823–1826.
92. [92] Matthews, D.C., Syed, A.A., The role of TSH receptor antibodies in the management of Graves’ disease. Eur J Intern Med 22 (2011), 213–216.
93. [93] Davis, L.E., Lucas, M.J., Hankins, G.D., Roark, M.L., Cunningham, F.G., Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160 (1989), 63–70.
94. [94] Khoo, C.M., Lee, K.O., Endocrine emergencies in pregnancy. Best Pract Res Clin Obstet Gynaecol 27 (2013), 885–891.
95. [95] Sullivan, S.A., Goodier, C., Endocrine emergencies. Obstet Gynecol Clin North Am 40 (2013), 121–135.
96. [96] Radetti, G., Zavallone, A., Gentili, L., Beck-Peccoz, P., Bona, G., Foetal and neonatal thyroid disorders. Minerva Pediatr 54 (2002), 383–400.
97. [97] Donnelly, M.A., Wood, C., Casey, B., Hobbins, J., Barbour, L.A., Early severe fetal Graves disease in a mother after thyroid ablation and thyroidectomy. Obstet Gynecol 125 (2015), 1059–1062.
98. [98] Alamdari, S., Azizi, F., Delshad, H., Sarvghadi, F., Amouzegar, A., Mehran, L., Management of hyperthyroidism in pregnancy: comparison of recommendations of american thyroid association and endocrine society. J Thyroid Res, 2013, 2013, 878467.
99. [99] Poppe, K., Velkeniers, B., Glinoer, D., The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab 4 (2008), 394–405.
100. [100] Chen, X., Jin, B., Xia, J., Tao, X., Huang, X., Sun, L., et al. Effects of thyroid peroxidase antibody on maternal and neonatal outcomes in pregnant women in an iodine-sufficient area in China. Int J Endocrinol, 2016, 2016, 6461380.
101. [101] Thangaratinam, S., Tan, A., Knox, E., Kilby, M.D., Franklyn, J., Coomarasamy, A., Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ, 342, 2011 d2616–d2616.
102. [102] Negro, R., Greco, G., Mangieri, T., Pezzarossa, A., Dazzi, D., Hassan, H., The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 92 (2007), 1263–1268.
103. [103] Fan, Y., Xu, S., Zhang, H., Cao, W., Wang, K., Chen, G., et al. Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol, 2014, 2014, 904573.
104. [104] Wilder, R.L., Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 840 (1998), 45–50.
105. [105] Kyriacou, A., Salazar, L.V., Ghattamaneni, S., Lymph nodes close to the thyroid isthmus can masquerade as malignant thyroid nodules in chronic lymphocytic thyroiditis. Int J Clin Endocrinol Metab 1 (2012), 37–39.
106. [106] Le Donne, M., Settineri, S., Benvenga, S., Early pospartum alexithymia and risk for depression: relationship with serum thyrotropin, free thyroid hormones and thyroid autoantibodies. Psychoneuroendocrinology 37 (2012), 519–533.
107. [107] Harris, B., Othman, S., Davies, J.A., Weppner, G.J., Richards, C.J., Newcombe, R.G., et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 305 (1992), 152–156.
108. [108] Bergink, V., Kushner, S.A., Pop, V., Kuijpens, H., Lambregtse-van den Berg, M.P., Drexhage, R.C., et al. Prevalence of autoimmune thyroid dysfunction in postpartum psychosis. Br J Psychiatry, 198, 2011.
109. [109] Engum, A., Bjøro, T., Mykletun, A., Dahl, A.A., Thyroid autoimmunity, depression and anxiety; are there any connections? An epidemiological study of a large population. J Psychosom Res 59 (2005), 263–268.
110. [110] Harris, B., Oretti, R., Lazarus, J., Parkes, A., John, R., Richards, C., et al. Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br J Psychiatry, 180, 2002.
111. [111] Nicholson, W.K., Robinson, K.A., Smallridge, R.C., Ladenson, P.W., Powe, N.R., Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid 16 (2006), 573–582.
112. [112] Lazarus, J.H., Ammari, F., Oretti, R., Parkes, A.B., Richards, C.J., Harris, B., Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 47 (1997), 305–308.
113. [113] Negro, R., Beck-Peccoz, P., Chiovato, L., Garofalo, P., Guglielmi, R., Papini, E., et al. Hyperthyroidism and pregnancy. An Italian Thyroid Association (AIT) and Italian Association of Clinical Endocrinologists (AME) joint statement for clinical practice. J Endocrinol Invest 34 (2011), 225–231.